Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bradbury, C. M.
Right arrow Articles by Gius, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bradbury, C. M.
Right arrow Articles by Gius, D.
[Cancer Research 61, 3486-3492, April 15, 2001]
© 2001 American Association for Cancer Research


Tumor Biology

Increased Activator Protein 1 Activity as Well as Resistance to Heat-induced Radiosensitization, Hydrogen Peroxide, and Cisplatin Are Inhibited by Indomethacin in Oxidative Stress-resistant Cells1

C. Matthew Bradbury2, Jacob E. Locke2, S. Jack Wei, Luis M. Rene, Shervin Karimpour, Clayton Hunt, Douglas R. Spitz and David Gius3

Section of Cancer Biology, Radiation Oncology Center, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri 63108 [C. M. B., J. E. L., S. J. W., L. M. R., S. K., D. G.], and Free Radical and Radiation Biology Program, Department of Radiology, B180 Medical Laboratories, University of Iowa, Iowa City, Iowa 52242 [D. R. S.]

It has been established that tumor cells develop resistance to a variety of therapeutic agents after multiple exposures to these agents/drugs. Many of these therapeutic agents also appear to increase the activity of transcription factors, such as activator protein 1 (AP-1), believed to be involved in cellular responses to oxidative stress. Therefore, we hypothesized that cellular resistance to cancer therapeutic agents may involve the increased activity of transcription factors that govern resistance to oxidative stress, such as AP-1. To investigate this hypothesis, a previously characterized cisplatin, hyperthermia, and oxidative stress-resistant Chinese hamster fibroblast cell line, OC-14, was compared to the parental HA-1 cell line. Electrophoretic mobility shift and Western blot assays performed on extracts isolated from OC-14 cells demonstrated a 10-fold increase in constitutive AP-1 DNA-binding activity as well as increased constitutive c-Fos and c-Jun immunoreactive protein relative to HA-1 cells. Treatment of OC-14 cells with indomethacin inhibited constitutive increases in AP-1 DNA-binding activity and c-Fos/c-Jun-immunoreactive protein levels. Clonogenic survival assays demonstrated that pretreatment with indomethacin, at concentrations that inhibited AP-1 activity, significantly reduced the resistance of OC-14 cells to heat-induced radiosensitization, hydrogen peroxide, and cisplatin. These results demonstrate a relationship between increases in AP-1 DNA-binding activity and increased cellular resistance to cancer therapeutic agents and oxidative stress that is inhibited by indomethacin. These results support the hypothesis that inhibition of AP-1 activity with nonsteroidal anti-inflammatory drugs, such as indomethacin, may represent a useful adjuvant to cancer therapy.




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
M. V. Mishra, K. S. Bisht, L. Sun, K. Muldoon-Jacobs, R. Awwad, A. Kaushal, P. Nguyen, L. Huang, J. D. Pennington, S. Markovina, et al.
DNMT1 as a Molecular Target in a Multimodality-Resistant Phenotype in Tumor Cells
Mol. Cancer Res., February 1, 2008; 6(2): 243 - 249.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. K. Smart, K. L. Ortiz, D. Mattson, C. M. Bradbury, K. S. Bisht, L. K. Sieck, M. W. Brechbiel, and D. Gius
Thioredoxin Reductase as a Potential Molecular Target for Anticancer Agents That Induce Oxidative Stress
Cancer Res., September 15, 2004; 64(18): 6716 - 6724.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. S. Bisht, C. M. Bradbury, D. Mattson, A. Kaushal, A. Sowers, S. Markovina, K. L. Ortiz, L. K. Sieck, J. S. Isaacs, M. W. Brechbiel, et al.
Geldanamycin and 17-Allylamino-17-demethoxygeldanamycin Potentiate the in Vitro and in Vivo Radiation Response of Cervical Tumor Cells via the Heat Shock Protein 90-Mediated Intracellular Signaling and Cytotoxicity
Cancer Res., December 15, 2003; 63(24): 8984 - 8995.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Lin, F. Zhang, C. M. Bradbury, A. Kaushal, L. Li, D. R. Spitz, R. L. Aft, and D. Gius
2-Deoxy-D-Glucose-induced Cytotoxicity and Radiosensitization in Tumor Cells Is Mediated via Disruptions in Thiol Metabolism
Cancer Res., June 15, 2003; 63(12): 3413 - 3417.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. M. Bradbury, S. Markovina, S. J. Wei, L. M. Rene, I. Zoberi, N. Horikoshi, and D. Gius
Indomethacin-induced Radiosensitization and Inhibition of Ionizing Radiation-induced NF-{kappa}B Activation in HeLa Cells Occur via a Mechanism Involving p38 MAP Kinase
Cancer Res., October 1, 2001; 61(20): 7689 - 7696.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.